Open Beta
TREN
MetriLume
TREN

US marketsVNOV

SEC-sourced researchBeta

VNOV

VitaNova Life Sciences Corp

Company comparison ↗

Data passport

CIK
0001699709
Exchange
OTC
Business activity
— · SIC 5130
Financial inputs
6/6
Filing date
Sep 14, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: April 2025: 2,662,105.0000 USD; April 2026: 3,025,538.0000 USD3M USD0 USD0April 2025April 2026
VNOV · Exact amounts and source periods · USD
Period endRevenueFiling date
April 20252,662,105.0000Jul 29, 2026
April 20263,025,538.0000Jul 29, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
April 20263,025,538.0000-37,304.0000814,407.00002,446,561.0000395,781.0000Jul 29, 2026
April 20252,662,105.0000850,746.0000192,774.00002,256,251.0000347,567.0000Jul 29, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$3.03MApril 2026Jul 29, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$2.66MApril 2025Jul 29, 202610-K
Net incomeNetIncomeLoss-$37.3KApril 2026Jul 29, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$814.41KApril 2026Jul 29, 202610-K
Total assetsAssets$2.45MApril 2026Jul 29, 202610-K
Total liabilitiesLiabilities$395.78KApril 2026Jul 29, 202610-K

New filings

Explore methodology ↗